Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chiara Zecchin"'
Autor:
Claudio Cobelli, Alberto Maran, Chiara Zecchin, Andrea Facchinetti, Mattia Zanon, Giovanni Sparacino
Publikováno v:
Sensors, Vol 12, Iss 10, Pp 13753-13780 (2012)
Monitoring glucose concentration in the blood is essential in the therapy of diabetes, a pathology which affects about 350 million people around the World (three million in Italy), causes more than four million deaths per year and consumes a signific
Externí odkaz:
https://doaj.org/article/3f4e2095d6e548eea3704c577b0f2f8c
Autor:
Christopher P Denton, Francesco del Galdo, Dinesh Khanna, Madelon C Vonk, Lorinda Chung, Sindhu R Johnson, John Varga, Daniel E Furst, Jane Temple, Chiara Zecchin, Eszter Csomor, Amy Lee, Nicolas Wisniacki, Shaun M Flint, Juliet Reid
Publikováno v:
Rheumatology, 62, 1, pp. 234-242
Rheumatology, 62, 234-242
Rheumatology, 62, 234-242
Objectives The cytokine oncostatin M (OSM) is implicated in the pathology of SSc. Inhibiting OSM signalling using GSK2330811 (an anti-OSM monoclonal antibody) in patients with SSc has the potential to slow or stop the disease process. Methods This mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13191ea52197ebad936014af1ae8cb1
https://doi.org/10.1093/rheumatology/keac300
https://doi.org/10.1093/rheumatology/keac300
Autor:
Juliet Reid, Stefano Zamuner, Maria Feeney, Chiara Zecchin, Disala Fernando, Ken Edwards, Katherine Nevin, Nicolas Wisniacki, Sally-Anne Rumley
Publikováno v:
British Journal of Clinical Pharmacology. 84:2280-2291
Aims The oncostatin M (OSM) pathway drives fibrosis, inflammation and vasculopathy, and is a potential therapeutic target for inflammatory and fibrotic diseases. The aim of this first-time-in-human experimental medicine study was to assess the safety
Publikováno v:
Journal of Diabetes Science and Technology. 10:1149-1160
Background: In type 1 diabetes (T1D) management, short-term glucose prediction can allow to anticipate therapeutic decisions when hypo/hyperglycemia is imminent. Literature prediction methods mainly use past continuous glucose monitoring (CGM) readin
Autor:
Juliet, Reid, Stefano, Zamuner, Ken, Edwards, Sally-Anne, Rumley, Katherine, Nevin, Maria, Feeney, Chiara, Zecchin, Disala, Fernando, Nicolas, Wisniacki
Publikováno v:
British journal of clinical pharmacology. 84(10)
The oncostatin M (OSM) pathway drives fibrosis, inflammation and vasculopathy, and is a potential therapeutic target for inflammatory and fibrotic diseases. The aim of this first-time-in-human experimental medicine study was to assess the safety, tol
Autor:
Anna Leigh Rack-Gomer, Thomas A. Peyser, Chiara Zecchin, Haripriyan Hampapuram, Apurv Ullas Kamath, Giovanni Sparacino, Andrea Facchinetti, Naresh C. Bhavaraju, Arturo Garcia, Claudio Cobelli
Publikováno v:
Journal of Diabetes Science and Technology. 7:1436-1445
Input from continuous glucose monitors (CGMs) is a critical component of artificial pancreas (AP) systems, but CGM performance issues continue to limit progress in AP research. While G4 PLATINUM has been integrated into AP systems around the world an
Aims The aims of this study were (i) to develop a modelling framework linking change in tumour size during treatment to survival probability in metastatic ovarian cancer; and (ii) to model the appearance of new lesions and investigate their relations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5f3d9018d057c666febbb2acad04f7
https://europepmc.org/articles/PMC5338128/
https://europepmc.org/articles/PMC5338128/
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1260
Prediction of the future value of a variable is of central importance in a wide variety of fields, including economy and finance, meteorology, informatics, and, last but not least important, medicine. For example, in the therapy of Type 1 Diabetes (T
Publikováno v:
Methods in Molecular Biology ISBN: 9781493922383
Prediction of the future value of a variable is of central importance in a wide variety of fields, including economy and finance, meteorology, informatics, and, last but not least important, medicine. For example, in the therapy of Type 1 Diabetes (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56ae030a0aea2619fcd20415d49adab1
https://doi.org/10.1007/978-1-4939-2239-0_15
https://doi.org/10.1007/978-1-4939-2239-0_15
Autor:
Chinmay U. Manohar, Andrea Facchinetti, Chiara Dalla Man, Claudio Cobelli, James A. Levine, Ananda Basu, Chiara Zecchin, Yogish C. Kudva, Giovanni Sparacino
In type 1 diabetes mellitus (T1DM), physical activity (PA) lowers the risk of cardiovascular complications but hinders the achievement of optimal glycemic control, transiently boosting insulin action and increasing hypoglycemia risk. Quantitative inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cd5b2240be5c78e567a184f9fd006b
https://europepmc.org/articles/PMC3781118/
https://europepmc.org/articles/PMC3781118/